MedPath

NEOGAP Therapeutics AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Phase 1
Recruiting
Conditions
Colorectal Cancer
Interventions
Drug: pTTL
First Posted Date
2023-06-18
Last Posted Date
2023-06-18
Lead Sponsor
Neogap Therapeutics AB
Target Recruit Count
16
Registration Number
NCT05908643
Locations
🇸🇪

Medical Unit Cell therapy and Allogeneic Stem cell Transplantation (ME CAST), and the Center for Clinical Cancer studies - Phase 1 unit, Karolinska University Hospital, Stockholm, Sweden

🇸🇪

Unit for Colorectal Surgery, Dept. of Surgery, Västmanlands Sjukhus Västerås, Västerås, Sweden

© Copyright 2025. All Rights Reserved by MedPath